FDA approval of a generic cephalexin oral suspension formulation; this is a regulatory action, not a clinical trial, and does not report efficacy or safety data.
Reported
Approval status date2026-06-09
Formulation 1 strengthCEPHALEXIN EQ 250MG BASE/5ML
Formulation 2 strengthCEPHALEXIN EQ 125MG BASE/5ML